Sexual dysfunction in depressed patients undergoing treatment with antidepressants

International Journal of Psychiatry in Clinical Practice

Volumn 4, Issue 4, 2000, Pages 311-317

  Merino, Maria Jesús ^a   González, Paz ^b   Muñiz, José ^b   Bobes, Julio ^b  

^a CSM El Coto   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Antidepressants; Depression; Sexual dysfunction; Sexual Function Questionnaire

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; MOCLOBEMIDE; NEFAZODONE; PAROXETINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSTHYMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RECURRENT DISEASE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION;

EID: 0034527680     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500050517885     Document Type: Article

References (44)

1. Sexual problems in healthy and depressed persons
2. Effects of antidepressant drugs on sexual function
3. Retrospective review of selective serotonin reuptake inhibitor induced libido disturbance in women
4. Lifetime psychopathology in individuals with low sexual desire
5. A psychological profile of the sexual dysfunctions
6. Sexual dysfunction and depression
7. Clinical observation in manic depressive disease
8. The natural history of affective disorders: I. Symptoms of 72 patients at the time of index hospital admissions
9. Sexual dysfunctions in depression
10. Assesment of paroxetine-induced sexual dysfunction using the changes in Sexual Functioning questionnaire
11. Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches
12. Sexual dysfunction during antidepressant treatment
13. Overview of sexual dysfunction complicating the treatment of depression
14. Clinical implications of antidepressant drug effects on sexual function
15. The biology of sexual function
16. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large scale retrospective study of 596 psychiatric outpatients
17. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
18. Effects of psychotropic drugs on human erection and ejaculation
19. Psychiatric drugs and sexuality
20. Priapism related to phenelzine therapy
21. Psychotropic medication and priapism: A comprehensive review
22. Priapism of the clitoris: A case report following trazodone use
23. Association of fluoxetine and return of sexual potency in three elderly men
24. Priapism associated with bupropion treatment
25. Effects of antidepressant medication on sexual function: A controlled study
26. Anorgasmia from clomipramine in obsessive-compulsive disorder: A controlled trial
27. Fluoxetine associated orgasm dysfunction
28. Evolutionary trends in the pharmacotherapeutic management of depression
29. Antidepressant-induced orgasm disorder
30. Sexual side-effects of psychotropic agents
31. Psychotropic drugs and sexual dysfunction
32. A review of multicenter controlled studies of fluoxetine versus imipramine and placebo in outpatients with major depressive disorder
33. Fluoxetine-induced sexual dysfunction
34. Male sexual side-effects associated with antidepressants. A descriptive clinical study of 32 patients
35. Fluoxetine associated orgasm dysfunction
36. A double blind comparison of paroxetine, imipramine, and placebo in depressed outpatients
37. Paroxetine: An overview of dosage, tolerability and safety
38. Psychotropics and sexuality
39. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study
40. Comparison of venlafaxine and imipramine in the acute treatment of major depression in out-patients
41. A comparison of venlafaxine, trazodone, and placebo in major depression
42. The safety profile of nefazodone
43. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
44. A comparison study of moclobemide and doxepine in major depression with special reference to effects on sexual dysfunction